摘要:
The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least one wild-type allergen fused to the N- and C-terminus of a surface polypeptide of a virus of the hepadnaviridae family or at least one fragment of said surface polypeptide.
摘要:
The present invention relates to a pharmaceutical composition comprising at least one polypeptide comprising an amino acid sequence consisting of a stretch of at least 80 consecutive amino acid residues of at least one full-length capsid protein of a rhinovirus for preventing and/or treating a rhinovirus infection.